𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance

✍ Scribed by Yuemeng Dai; Cheng-hui Xie; John P. Neis; Chun-Yang Fan; Emre Vural; Paul M. Spring

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
220 KB
Volume
33
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

The purpose of this study was to investigate the potential role of variable microRNA (miRNA) expression in the development of multidrug resistance (MDR) in head and neck cancer.

Methods

Head and neck squamous cell carcinoma cell lines UMSCC‐1 and SQ20B were treated with docetaxel at increasing concentrations to develop resistant cell lines. Parental and resistant cells were treated with cisplatin, 5‐fluorouracil, paclitaxel, methotrexate, and doxorubicin to confirm cross‐resistance. The miRNA pattern of resistant cells was then compared with their parental cells.

Results

Docetaxel treatment successfully induced resistance primarily and induced multidrug cross‐resistance. Resistant cells showed significant downregulation of miR‐100, miR‐130a, and miR‐197 and upregulation in miR‐101, miR‐181b, miR‐181d, and miR‐195 expression when compared with their parent cells (p < .01). Real‐time polymerase chain reaction (PCR) analysis confirmed statistically significant downregulation in miR‐100 and miR‐130a and upregulation in miR‐181d expression (p < .001).

Conclusion

Alterations in miRNA expression has direct relationship to MDR in head and neck cancer and may serve as biomolecular targets for reversal of MDR. © 2010 Wiley Periodicals, Inc. Head Neck, 2011

📜 SIMILAR VOLUMES

Evaluation of drug transporters' signifi
Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma
✍ Dirk Theile; Nahal Ketabi-Kiyanvash; Christel Herold-Mende; Gerhardt Dyckhoff; T 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 1 views

## Abstract ## Background. Multidrug resistance (MDR) hampers chemotherapy in head and neck squamous cell carcinoma (HNSCC). There is little information about MDR mediating drug transporters in HNSCC. ## Methods. Nine HNSCC cell lines were characterized concerning drug transporter expression and

Aberrant cytokine expression in serum of
Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck
✍ Thomas K. Hoffmann; Eniko Sonkoly; Bernhard Homey; Katrin Scheckenbach; Christia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Background. Squamous cell carcinoma (SCC) and adenoid cystic carcinoma (ACC) represent 2 clinically important subtypes of head and neck cancer. Our objective was to characterize and compare cytokine profiles in the systemic circulation of patients with SCC and ACC. ## Methods. Mul

Downregulation of SERPINB13 expression i
Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome
✍ Pieter J.A. de Koning; Niels Bovenschen; Frank K.J. Leusink; Roel Broekhuizen; R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 376 KB

## Abstract Tumorigenesis of head and neck squamous cell carcinomas (HNSCC) is associated with various genetic changes such as loss of heterozygosity (LOH) on human chromosome 18q21. This chromosomal region maps a gene cluster coding for a family of intracellular serine protease inhibitors (serpins